LAMEA Needle Free Injection System Market By Product (Prefilled Needle-Free Injectors, Fillable Needle-Free Injectors), Technology (Jet-Based, Spring-Based, Laser-Powered, Vibration-Based), Type (Liquid-Based, Projectile/Depot-Based, Powder-Based), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Usability, Application, End Users
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Needle Free Injection System Market
The Latin America, Middle East and Africa Needle Free Injection System Market would witness market growth of 16.8% CAGR during the forecast period (2018-2024). Needle free injection technology (NFIT) includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lorentz, Shock waves, pressure by gas or electrophoresis. The process propels the drug to pass through the skin, and virtually nullifies the use of hypodermic needles.
The technology is highly beneficial in the pharma industry and also it is widely popular in the developing countries, as it is used in mass immunization programmes, bypassing the chances of needle stick injuries and avoiding other complications including those arising due to multiple use of single needle. As these systems improve the immune response to vaccines, eliminate risks of needles, and reduce healthcare costs, the demand for these systems has witnessed unprecedented demand. Demand for these systems has increased considerably in the recent years as they improve. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration would be factors that limit the market growth.
On the basis of Product, the market is segmented into Prefilled Needle-Free Injectors and Fillable Needle-Free Injectors. Technology is categorized into Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, and Vibration-Based Needle-Free Injectors. On the basis of Type, the market is segmented into Liquid-Based Needle Free Injectors, Projectile/Depot-Based Needle-Free Injectors, and Powder-Based Needle Free Injectors. By Site of delivery, the market is divided into Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors. Usability has been segmented into Reusable Needle-Free Injectors and Disposable Needle-Free Injectors. On the basis of Application, the market is categorized into Vaccine Delivery, Insulin Delivery, Pain Management, and Other Applications. The End Users covered under the report are Hospitals and Clinics, Home Care Settings, Research Laboratories, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA. The market research report covers the analysis of key stake holders of the market.
Key companies profiled in the report include Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), National Medical Product Inc, Valeritas Inc, European Pharma Group BV, Portal Instruments, Injex Pharma AG, Bioject Medical Technologies Inc.